A University of Colorado Cancer Center study published in the Journal of Clinical Investigation shows that the protein SPARC (Secreted Protein Acidic and Rich in Cysteine) acts much like an anti-inflammatory drug, attempting to heal tissues inflamed by tumors. Likewise, cancers – for example, bladder cancer in this study – have developed ways to turn off the production of SPARC, thus allowing growth and metastasis, especially to the lung where bladder cancer is frequently fatal. Read more here.
Study mentioned: Said N, et al. Loss of SPARC in bladder cancer enhances carcinogenesis and progression. J Clin Invest. 2013 Jan 16. [Epub ahead of print] PMID: 23321672
No comments:
Post a Comment